Home › Compare › MRVT vs JEPQ

MRVT vs JEPQ: Dividend Comparison 2026

MRVT yields 66666.67% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRVT wins by $8.441837856534449e+24M in total portfolio value
10 years
MRVT
MRVT
● Live price
66666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.441837856534449e+24M
Annual income
$8,417,001,582,403,749,000,000,000,000,000.00
Full MRVT calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — MRVT vs JEPQ

📍 MRVT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMRVTJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MRVT + JEPQ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MRVT pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MRVT
Annual income on $10K today (after 15% tax)
$5,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$7,154,451,345,043,187,000,000,000,000,000.00/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, MRVT beats the other by $7,154,451,345,043,187,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MRVT + JEPQ for your $10,000?

MRVT: 50%JEPQ: 50%
100% JEPQ50/50100% MRVT
Portfolio after 10yr
$4.2209189282672247e+24M
Annual income
$4,208,500,791,201,874,400,000,000,000,000.00/yr
Blended yield
99.71%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MRVT buys
0
JEPQ buys
0
No recent congressional trades found for MRVT or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMRVTJEPQ
Forward yield66666.67% ✓11.10%
Annual dividend / share$2.00$6.16 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$8.441837856534449e+24M$44.8K ✓
Annual income after 10y$8,417,001,582,403,749,000,000,000,000,000.00 ✓$2,152.59
Total dividends collected$8.44020886744369e+24M$16.3K ✓
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: MRVT vs JEPQ ($10,000, DRIP)

YearMRVT PortfolioMRVT Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$6,677,367$6,666,666.67$11,930$1,110.39+$6.67M → MRVT
2$4,167,497,846$4,160,353,063.34$14,133$1,224.34+$4167.48M → MRVT
3$2,431,161,901,635$2,426,702,678,939.67$16,632$1,340.46+$2431161.89M → MRVT
4$1,325,636,209,022,888$1,323,034,865,788,139.00$19,454$1,457.97+$1325636209.00M → MRVT
5$675,632,775,263,916,700$674,214,344,520,262,300.00$22,626$1,576.08+$675632775263.89M → MRVT
6$321,867,481,182,444,260,000$321,144,554,112,911,900,000.00$26,175$1,694.09+$321867481182444.25M → MRVT
7$143,326,993,661,751,470,000,000$142,982,595,456,886,240,000,000.00$30,133$1,811.32+$143326993661751472.00M → MRVT
8$59,657,925,421,851,500,000,000,000$59,504,565,538,633,426,000,000,000.00$34,531$1,927.17+$59657925421851500544.00M → MRVT
9$23,211,471,150,187,795,000,000,000,000$23,147,637,169,986,416,000,000,000,000.00$39,403$2,041.08+$2.3211471150187796e+22M → MRVT
10$8,441,837,856,534,450,000,000,000,000,000$8,417,001,582,403,749,000,000,000,000,000.00$44,787$2,152.59+$8.441837856534449e+24M → MRVT

MRVT vs JEPQ: Complete Analysis 2026

MRVT — Stock

Miravant Medical Technologies Inc. operates as a pharmaceutical research and development company. The company develops PhotoPoint, a photodynamic therapy that responds to light destroying cancerous cells; and manufactures light producing and light delivery devices. Its products include PHOTREX for the treatment of wet age-related macular degeneration or AMD; MV9411, a photoreactive drug for the treatment of plaque psoriasis; MV0633 for the treatment of atherosclerosis, atherosclerotic vulnerable plaque, and restenosis; MV2101 for the treatment of vascular access graft disease in hemodialysis patients; and MV6401 for the treatment of solid tumors. Miravant Medical Technologies Inc. was formerly known as PDT, Inc. and changed its name to Miravant Medical Technologies Inc. in September 1997. The company was founded in 1989 and is headquartered in Santa Barbara, California.

Full MRVT Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this MRVT vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MRVT vs SCHDMRVT vs JEPIMRVT vs OMRVT vs KOMRVT vs MAINMRVT vs XYLDMRVT vs QYLDMRVT vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.